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Protective Effects of Insulin in Cardiomyocytes Against Iron-mediated Cell Death
Abstract
When an acute myocardial infarction (MI) occurs, the heart becomes ischemic. Medical treatments such
as stents have improved the recovery process after a MI, but there is still a high risk for heart failure. Due
to the resulting intramyocardial hemorrhage, residual hemoglobin with excess iron compromises
cardiomyocyte (CM) survival. Previous studies suggest that the magnitude of CM cell death is directly
proportional to the level of adverse left ventricular (LV) remodeling. Mechanistic target of rapamycin
(mTOR) is a key downstream signaling pathway that is sufficient for CM cell survival against iron and
responds to insulin, a cardioprotective growth factor. However, the effect of insulin in excess iron-induced
cell death in CMs is not well characterized. Using H9c2 cardiomyoblasts, originally derived from
embryonic rat ventricle cells, the effects of insulin in CM cell survival against excess iron were examined.
The cells were pre-treated with varying dosages of insulin before applying iron (III) citrate. Cell viability
was assessed by Live/Dead Assay, in which live cells stain with calcein AM (green) and nuclei of dead
cells stain with ethidium homodimer-1 (red). In comparison to the amount of cell death caused by iron
alone, insulin decreased dead cell count substantially. The greatest concentration of 1µM of insulin with
iron resulted in a statistical significance of p<0.02 (n=3-4). The results indicate that insulin has the
potential to mediate iron-induced CM death. Understanding the effect of insulin as a combatant of ironinduced cell death with an intramyocardial approach would lead to better therapeutic preventions of heart
failure.
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ABSTRACT
When an acute myocardial infarction (MI) occurs, the heart becomes ischemic. Medical
treatments such as stents have improved the recovery process after a MI, but there is still a high
risk for heart failure. Due to the resulting intramyocardial hemorrhage, residual hemoglobin with
excess iron compromises cardiomyocyte (CM) survival. Previous studies suggest that the
magnitude of CM cell death is directly proportional to the level of adverse left ventricular (LV)
remodeling. Mechanistic target of rapamycin (mTOR) is a key downstream signaling pathway that
is sufficient for CM cell survival against iron and responds to insulin, a cardioprotective growth
factor. However, the effect of insulin in excess iron-induced cell death in CMs is not well
characterized. Using H9c2 cardiomyoblasts, originally derived from embryonic rat ventricle cells,
the effects of insulin in CM cell survival against excess iron were examined. The cells were pretreated with varying dosages of insulin before applying iron (III) citrate. Cell viability was assessed
by Live/Dead Assay, in which live cells stain with calcein AM (green) and nuclei of dead cells
stain with ethidium homodimer-1 (red). In comparison to the amount of cell death caused by iron
alone, insulin decreased dead cell count substantially. The greatest concentration of 1µM of insulin
with iron resulted in a statistical significance of p<0.02 (n=3-4). The results indicate that insulin
has the potential to mediate iron-induced CM death. Understanding the effect of insulin as a
combatant of iron-induced cell death with an intramyocardial approach would lead to better
therapeutic preventions of heart failure.
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